2 most recent filings and news items mentioning DTIL. Updated every 60 seconds.
RegulatoryMay 27, 2026Positive
Precision BioSciences announced late-breaking clinical data from the ELIMINATE-B study demonstrating that PBGENE-HBV directly eliminated cccDNA with a 10-fold reduction in viral transcripts and achieved pgRNA loss in 100% of treated patients. The data represent a potential breakt
View filing at SEC.gov →
RegulatoryMay 26, 2026Neutral
Precision BioSciences adopted a certificate amendment expanding protections for directors and officers from personal liability for breaches of fiduciary duty, subject to Delaware law limits. The amendment enhances corporate governance flexibility and director indemnification prov
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.